Short‐Term Results of IPS‐Empress Inlays and Onlays

DOI Web Site Web Site 被引用文献3件

抄録

<jats:p><jats:bold>Purpose</jats:bold> A leucite‐reinforced, glass‐ceramic material was recently introduced for clinical use. In this clinical trial, IPS‐Empress inlays and onlays were evaluated using the modified United States Public Health Service (USPHS) criteria.</jats:p><jats:p><jats:bold>Materials and Methods</jats:bold> The teeth of 36 patients were restored with 105 posterior inlays and 25 onlays, fabricated by an indirect technique. After etching the restorations with hydrofluoric acid, they were silanized and luted using composite cements. The restorations were evaluated visually, clinically with a mirror and probe, and by bitewing radiographs and clinical photographs, using modified USPHS criteria. Restorations having neither charlie nor delta criteria were defined as successful, and their survival rate was calculated according to Kaplan‐Meier analysis.</jats:p><jats:p><jats:bold>Results</jats:bold> The mean observation period for the 130 restorations was 23.4 ± 6.1 months. After 2 years, 127 restorations were successful with an estimated survival rate of 97.5%. Three restorations failed because of fractures. The esthetic results were excellent.</jats:p><jats:p><jats:bold>Conclusions</jats:bold> The initial clinical results of this esthetic restorative material are encouraging. However, because of fatigue phenomena for all ceramic materials, a longer observation period is needed to provide a definitive prognosis of the long‐term clinical behavior.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ